Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 285

1.

Neuromyelitis optica spectrum disorder in three generations of a Chinese family.

Wei X, Zhang S, Yang W, Luo Z, Sun P, Dalton CF, Fachim HA, Reynolds GP.

Mult Scler Relat Disord. 2019 May 4;32:94-96. doi: 10.1016/j.msard.2019.04.010. [Epub ahead of print]

PMID:
31075495
2.

Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in Rats.

Reynolds GP, Dalton CF, Watrimez W, Jackson J, Harte MK.

Clin Psychopharmacol Neurosci. 2019 May 31;17(2):314-317. doi: 10.9758/cpn.2019.17.2.314.

3.

GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function.

Fachim HA, Loureiro CM, Corsi-Zuelli F, Shuhama R, Louzada-Junior P, Menezes PR, Dalton CF, Del-Ben CM, Reynolds GP.

Epigenomics. 2019 Feb;11(4):401-410. doi: 10.2217/epi-2018-0127. Epub 2019 Feb 20.

PMID:
30785307
4.

Parvalbumin promoter hypermethylation in postmortem brain in schizophrenia.

Fachim HA, Srisawat U, Dalton CF, Reynolds GP.

Epigenomics. 2018 May;10(5):519-524. doi: 10.2217/epi-2017-0159. Epub 2018 Apr 24.

PMID:
29688033
5.

Lower uric acid is associated with poor short-term outcome and a higher frequency of posterior arterial involvement in ischemic stroke.

Liu H, Reynolds GP, Wang W, Wei X.

Neurol Sci. 2018 Jun;39(6):1117-1119. doi: 10.1007/s10072-018-3307-4. Epub 2018 Mar 6.

PMID:
29511962
6.

Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.

Iamjan SA, Thanoi S, Watiktinkorn P, Reynolds GP, Nudmamud-Thanoi S.

J Psychopharmacol. 2018 Mar;32(3):309-315. doi: 10.1177/0269881117750153. Epub 2018 Jan 17.

PMID:
29338492
7.

Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.

Reynolds GP, McGowan OO.

J Psychopharmacol. 2017 Nov;31(11):1430-1436. doi: 10.1177/0269881117722987. Epub 2017 Sep 11. Review.

PMID:
28892404
8.

Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.

Veerasakul S, Watiktinkorn P, Thanoi S, Dalton CF, Fachim HA, Nudmamud-Thanoi S, Reynolds GP.

Pharmacogenomics. 2017 Sep;18(14):1317-1322. doi: 10.2217/pgs-2016-0188. Epub 2017 Aug 24.

PMID:
28835159
9.
10.

Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence.

Veerasakul S, Watiktinkorn P, Thanoi S, Reynolds GP, Nudmamud-Thanoi S.

Pharmacogenomics. 2017 Jan;18(1):17-22. doi: 10.2217/pgs-2016-0101. Epub 2016 Dec 14.

PMID:
27967329
11.

TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs.

Xu Z, Reynolds GP, Yuan Y, Shi Y, Pu M, Zhang Z.

Int J Neuropsychopharmacol. 2016 Nov 1;19(11). pii: pyw070. doi: 10.1093/ijnp/pyw070. Print 2016 Nov.

12.

Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder.

Nazree NE, Mohamed Z, Reynolds GP, Mohd Zain S, Masiran R, Sidi H, Chong LA, Hway AY, Adlan AS, Zainal NZ.

Asia Pac Psychiatry. 2016 Dec;8(4):260-268. doi: 10.1111/appy.12210. Epub 2015 Sep 10.

PMID:
27787964
13.

DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.

Ding K, Yang J, Reynolds GP, Chen B, Shao J, Liu R, Qian Q, Liu H, Yang R, Wen J, Kang C.

World J Biol Psychiatry. 2017 Jun;18(4):291-299. doi: 10.1080/15622975.2016.1224928. Epub 2016 Sep 27.

PMID:
27676100
14.

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.

Reynolds GP, Neill JC.

J Psychopharmacol. 2016 Nov;30(11):1141-1144. Epub 2016 Sep 13. Review.

PMID:
27624147
15.

Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain.

Fachim HA, Srisawat U, Dalton CF, Harte MK, Marsh S, Neill JC, Reynolds GP.

Epigenomics. 2016 Sep;8(9):1179-83. doi: 10.2217/epi-2016-0050. Epub 2016 Aug 16.

PMID:
27529801
16.

Blood oxygen level-dependent signals via fMRI in the mood-regulating circuit using two animal models of depression are reversed by chronic escitalopram treatment.

Hui JJ, Xi GJ, Liu SS, Li XL, Geng LY, Teng GJ, Nie BB, Shan BC, Yan J, Dong L, Reynolds GP, Zhang ZJ.

Behav Brain Res. 2016 Sep 15;311:210-218. doi: 10.1016/j.bbr.2016.05.044. Epub 2016 May 24.

PMID:
27233829
17.

Effect of Methamphetamine Exposure on Expression of Calcium Binding Proteins in Rat Frontal Cortex and Hippocampus.

Veerasakul S, Thanoi S, Reynolds GP, Nudmamud-Thanoi S.

Neurotox Res. 2016 Oct;30(3):427-33. doi: 10.1007/s12640-016-9628-2. Epub 2016 May 14.

PMID:
27179799
18.

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Cooper SJ, Reynolds GP; With expert co-authors (in alphabetical order):, Barnes T, England E, Haddad PM, Heald A, Holt R, Lingford-Hughes A, Osborn D, McGowan O, Patel MX, Paton C, Reid P, Shiers D, Smith J.

J Psychopharmacol. 2016 Aug;30(8):717-48. doi: 10.1177/0269881116645254. Epub 2016 May 4.

PMID:
27147592
19.

Does DNA methylation influence the effects of psychiatric drugs?

Reynolds GP, Fachim HA.

Epigenomics. 2016 Mar;8(3):309-12. doi: 10.2217/epi.15.116. Epub 2016 Feb 26. No abstract available.

20.

Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?

Veerasakul S, Thanoi S, Watiktinkorn P, Reynolds GP, Nudmamud-Thanoi S.

Hum Psychopharmacol. 2016 May;31(3):243-6. doi: 10.1002/hup.2523. Epub 2016 Feb 24.

PMID:
26913858

Supplemental Content

Loading ...
Support Center